# Post-Operative Pain Management

---

## Definition
Acute pain arising after surgery, resulting from tissue injury, inflammation, and nociceptive/neuropathic pathways.  

- **Numeric Rating Scale (NRS 0–10)** for verbal adults.  
- **Critical Care Pain Observation Tool (CPOT)** or **FLACC scale** for non-verbal or pediatric patients.  
- Uncontrolled pain worsens outcomes: delayed ambulation, pulmonary complications, delirium, and chronic pain syndromes.

---

## I. Principles
- **Multimodal therapy is standard**: combine non-opioids, opioids, and regional techniques.  
- **Oral > IV** whenever feasible.  
- **Start least invasive, escalate stepwise.**  
- Always rule out **dangerous causes** of pain: peritonitis, bleeding, anastomotic leak, compartment syndrome, ischemia.  
- **Regular reassessment**: q2–4h depending on setting.  
- **Prevent complications**: constipation, oversedation, delirium, respiratory depression.  
- **Tailor to special populations**: frail, elderly, renal/hepatic impairment, pediatrics, opioid-tolerant patients.  

---

## II. Stepwise Framework

### **Step 1: Scheduled Non-Opioids** (baseline for all unless contraindicated)
- **Acetaminophen**  
  - 650 mg PO q6h OR 1 g PO/IV q6–8h  
  - Max: 4 g/day (≤3 g in frail, liver disease, alcohol use).  

- **NSAIDs** *(avoid in renal impairment, GI ulcer, coagulopathy, or fresh anastomosis)*  
  - Ketorolac 15–30 mg IV q6h (max 5 days).  
  - Ibuprofen 400–600 mg PO q6h.  

- **Adjuncts**  
  - Gabapentin 100–300 mg PO qHS (titrate to 300 TID; renal adjust).  
  - Robaxin (methocarbamol) 500–1000 mg PO/IV q8h PRN.  
  - Flexeril (cyclobenzaprine) 5–10 mg PO TID PRN.  
  - Lidocaine patches (12h on/12h off) for incisional pain.  

---

### **Step 2: PRN Oral Opioids** (breakthrough pain)
- Oxycodone IR 5–10 mg PO q4–6h PRN.  
- Hydromorphone PO 2–4 mg PO q4–6h PRN.  
- Hydrocodone/APAP (Norco 5/325 mg) 1–2 tabs PO q6h PRN *(track acetaminophen total).*  
- Tramadol 50 mg PO q6h PRN *(max 400 mg/day; serotonin syndrome risk with SSRIs/SNRIs).*  

---

### **Step 3: IV Opioids** (if NPO, severe pain, or unable to tolerate PO)
- Hydromorphone 0.2–0.5 mg IV q2–3h PRN.  
- Morphine 1–2 mg IV q2–3h PRN *(avoid in renal impairment).*  
- Fentanyl 25–50 mcg IV q1–2h PRN *(short acting).*  

---

### **Step 4: Escalation / Severe or Refractory Pain**
- **PCA (Patient-Controlled Analgesia):**  
  - Hydromorphone: 0.2 mg demand, lockout 8–10 min, no basal in opioid-naïve.  
  - Morphine: 1 mg demand, lockout 8–10 min.  
  - Add basal infusion only if opioid-tolerant or ICU monitored.  

- **Acute Pain Service consult** for uncontrolled pain, opioid tolerance, or consideration of regional/epidural techniques.  

- **Regional / Neuraxial:**  
  - Epidural infusion (thoracic/lumbar).  
  - TAP block or wound infusion catheter.  
  - Coordinate with anesthesia/pain service.  

---

## III. Monitoring & Safety
- **Assessment frequency:**  
  - Floor: q4h.  
  - ICU: q2h (NRS or CPOT if non-verbal).  

- **Side effect management:**  
  - Nausea → ondansetron 4 mg IV/PO q8h PRN.  
  - Constipation → senna scheduled ± miralax.  
  - Pruritus → diphenhydramine or nalbuphine.  
  - Respiratory depression → naloxone 0.1–0.2 mg IV q2–3 min PRN (max 0.8 mg).  

- **Special populations:**  
  - Elderly/frail → lower doses, slower titration.  
  - Renal impairment → avoid morphine, adjust gabapentin, avoid ketorolac.  
  - Hepatic impairment → acetaminophen max ≤2–3 g/day.  

---

## IV. Pediatric Considerations
- **Pain assessment tools:** FLACC (Face, Legs, Activity, Cry, Consolability), Wong-Baker FACES, Numeric scale (if verbal).  
- **Non-pharmacologic adjuncts:** parental presence, distraction (music, video), comfort positioning.  

- **Stepwise regimen (weight-based):**  
  - **Acetaminophen:** 10–15 mg/kg PO/IV q6h (max 75 mg/kg/day, not exceeding 4 g).  
  - **Ibuprofen:** 5–10 mg/kg PO q6–8h *(avoid <6 months or renal/GI risk).*  
  - **Opioids:**  
    - Morphine 0.05–0.1 mg/kg IV q2–4h PRN.  
    - Hydromorphone 0.01–0.02 mg/kg IV q3–4h PRN.  
    - Oxycodone 0.05–0.15 mg/kg PO q4–6h PRN.  
  - **Avoid codeine & tramadol** (variable metabolism, black box warning).  

- **Regional techniques:** caudal block, epidural, nerve blocks often used safely in pediatrics.  

- **Cautions:** infants <6 months at higher risk of respiratory depression.  

---

## V. Red Flags / Urgent Triggers
- **Disproportionate pain** to expected course.  
- **Sudden severe pain** with instability → consider hemorrhage, anastomotic leak, perforation.  
- **New focal deficits** → compartment syndrome, ischemia, nerve injury.  
- **Opioid-induced oversedation or respiratory depression.**  

---

## VI. Intern Pearls
- Always schedule **acetaminophen + NSAID** unless contraindicated.  
- Opioids should be **PRN, not scheduled.**  
- Always **reassess vitals and pain** after each escalation step.  
- Disproportionate pain = **work up for complication, not just medicate.**  
- In ICU: prioritize **analgesia over sedation.**  
- If delirium develops: reduce opioids/benzos, add delirium precautions.  

---

## VII. Summary Tables

### Non-Opioids

| Drug | Dose / Route | Notes / Cautions |
|------|-------------|------------------|
| Acetaminophen | 650 mg PO q6h OR 1 g IV q6–8h | Max 4 g/day (≤3 g in liver dz) |
| Ketorolac | 15–30 mg IV q6h (≤5 days) | Avoid renal/GI/bleeding risk |
| Ibuprofen | 400–600 mg PO q6h | Avoid GI ulcer, renal impairment |
| Gabapentin | 100–300 mg PO qHS → TID | Renal adjust |
| Robaxin | 500–1000 mg IV/PO q8h PRN | Limit IV ≤3 days, avoid severe renal impairment |
| Flexeril | 5–10 mg PO TID PRN | Oversedation risk |
| Lidocaine patch | Apply over incision, 12h on/12h off | Useful for incisional pain |

### Opioids

| Drug | Dose / Route | Notes / Cautions |
|------|-------------|------------------|
| Oxycodone IR | 5–10 mg PO q4–6h PRN | 1st-line oral opioid |
| Hydromorphone PO | 2–4 mg PO q4–6h PRN | Stronger oral option |
| Hydrocodone/APAP | 1–2 tabs PO q6h PRN | Track total APAP dose |
| Tramadol | 50 mg PO q6h PRN (max 400 mg/day) | Risk serotonin syndrome |
| Hydromorphone IV | 0.2–0.5 mg IV q2–3h PRN | Preferred IV opioid |
| Morphine IV | 1–2 mg IV q2–3h PRN | Avoid in renal impairment |
| Fentanyl IV | 25–50 mcg IV q1–2h PRN | Short acting |
| PCA (Hydromorphone) | 0.2 mg demand, lockout 8–10 min | No basal if opioid-naïve |
| PCA (Morphine) | 1 mg demand, lockout 8–10 min | Basal only if opioid-tolerant |

---

## VIII. References
- Barr J, Fraser GL, Puntillo K, et al. **Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the ICU.** *Crit Care Med.* 2013;41(1):263–306.  
- Devlin JW, Skrobik Y, Gélinas C, et al. **PADIS Guidelines (Pain, Agitation/Sedation, Delirium, Immobility, Sleep).** *Crit Care Med.* 2018;46(9):e825–e873.  
- El Moheb M. **Use of Opioids in the Postoperative Period.** In: *Current Surgical Therapy, 14th ed.* Elsevier, 2023.  
- Washington Manual of Surgery, 9th ed. LWW, 2024.  
- American Pediatric Surgical Association (APSA) & American Pain Society pediatric recommendations (consensus-based).  

---
